ABS Bio Acquires Cureline To Expand Biospecimen Procurement And Histology Capabilities
By Amit Chowdhry ● Jan 7, 2026
Analytical Biological Services (ABS Bio), a biospecimen sourcing, cell culture, and biorepository solutions provider backed by 3 Boomerang Capital, has acquired Cureline, Inc., a specimen procurement and histology services firm serving pharmaceutical and life sciences customers. The deal, announced January 6, 2026, is ABS Bio’s first add-on acquisition since 3 Boomerang’s initial investment in June 2024.